0001209191-15-009190.txt : 20150203 0001209191-15-009190.hdr.sgml : 20150203 20150203204944 ACCESSION NUMBER: 0001209191-15-009190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150130 FILED AS OF DATE: 20150203 DATE AS OF CHANGE: 20150203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piatt Rodney L CENTRAL INDEX KEY: 0001299427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 15573255 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-30 0 0000069499 MYLAN INC. MYL 0001299427 Piatt Rodney L 1000 MYLAN BLVD CANONSBURG PA 15317 1 0 0 0 Common Stock 2015-01-30 4 M 0 8190 20.86 A 57325 D Common Stock 2015-01-30 4 S 0 12558 53.7283 D 44767 D Common Stock 2015-02-02 4 M 0 1810 20.86 A 46577 D Common Stock 2015-02-02 4 M 0 10000 22.00 A 56577 D Common Stock 2015-02-02 4 M 0 990 15.80 A 57567 D Common Stock 2015-02-02 4 S 0 19627 52.8739 D 37940 D Common Stock 2015-02-03 4 M 0 9010 15.80 A 46950 D Common Stock 2015-02-03 4 S 0 13815 53.0135 D 33135 D Non-Employee Director Stock Option - Right to Buy 20.86 2015-01-30 4 M 0 8190 0.00 D 2015-11-28 Common Stock 8190 1810 D Non-Employee Director Stock Option - Right to Buy 20.86 2015-02-02 4 M 0 1810 0.00 D 2015-11-28 Common Stock 1810 0 D Non-Employee Director Stock Option - Right to Buy 22.00 2015-02-02 4 M 0 10000 0.00 D 2016-07-28 Common Stock 10000 0 D Non-Employee Director Stock Option - Right to Buy 15.80 2015-02-02 4 M 0 990 0.00 D 2017-07-27 Common Stock 990 9010 D Non-Employee Director Stock Option - Right to Buy 15.80 2015-02-03 4 M 0 9010 0.00 D 2017-07-27 Common Stock 9010 0 D Represents acquisition of Mylan common stock upon exercise of stock options granted on November 28, 2005. Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on January 30, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 403,595 shares in transactions ranging from $53.01 to $54.00 with a weighted average price of $53.5684 as well as 205,341 shares in transactions ranging from $54.005 to $54.25 with a weighted average price of $54.0425. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person. These sales of common stock were executed pursuant to 10b5-1 trading plans dated November 9, 2014. Represents acquisition of Mylan common stock upon exercise of stock options granted on July 28, 2006. Represents acquisition of Mylan common stock upon exercise of stock options granted on July 27, 2007. Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 2, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 937,763 shares in transactions ranging from $52.23 to $53.22 with a weighted average price of $52.8646 as well as 13,957 shares in transactions ranging from $53.23 to $53.745 with a weighted average price of $53.5027. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person. These sales of common stock were executed pursuant to 10b5-1 trading plans dated November 9, 2014. Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 3, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 520,475 shares in transactions ranging from $52.50 to $53.25 with a weighted average price of $52.8739 as well as 149,400 shares at $53.50 and 1 share at $54.50. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person. These sales of common stock were executed pursuant to 10b5-1 trading plans dated November 9, 2014. This option exercise was executed pursuant to a 10b5-1 trading plan dated November 9, 2014. These options vested in full on November 28, 2005. These options vested in full on July 28, 2006. These options vested in full on July 27, 2007. As disclosed in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014, the filing person has exercised the stock options shown on this Form 4 to mitigate the effects of the excise tax under Section 4985 of the Internal Revenue Code of 1986, as amended, in connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business and has sold the shares reported on this Form 4 to mitigate the tax and other costs imposed as a result of such exercises and the Transaction. /s/ Bradley L. Wideman, by power of attorney 2015-02-03